Class | Num Shares | Value | Price $ | Report Date | Ownership | Underlying Class | Underlying Amount |
---|---|---|---|---|---|---|---|
Common Stock | 5.47 M | $65.6 M | $11.98 | Sep 19, 2023 | F-Prime Capital Partners Life Sciences Fund VII LP | ||
Common Stock | 88.3 K | $1.06 M | $11.98 | Sep 19, 2023 | FBRI LLC | ||
Common Stock | 63.7 K | $763 K | $11.98 | Sep 19, 2023 | F-Prime Inc. | ||
Series A-2 Preferred Stock | 0 | Sep 19, 2023 | FBRI LLC | Common Stock | |||
Series A-2 Preferred Stock | 0 | Sep 19, 2023 | F-Prime Capital Partners Life Sciences Fund VII LP | Common Stock | |||
Series A-2 Preferred Stock | 0 | Sep 19, 2023 | F-Prime Inc. | Common Stock | |||
Series B Preferred Stock | 0 | Sep 19, 2023 | F-Prime Capital Partners Life Sciences Fund VII LP | Common Stock |
Sym | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|